The session, neither flashy nor timid, carried an air of unflustered determination as legislators sought to address gaps that had marred the 1976 Drugs Act for decades.
By incorporating therapeutic goods, including medicines and medical devices into the historic Act, the bill introduces a pivotal, long awaited shift toward a more adequate and comprehensive regulatory framework.
The decision, some legislators allege, had been delayed precariously for years, caught between bureaucratic hurdles and mounting pressure from both industry and consumers.
The amendment adds a formal definition of ‘therapeutic goods’ to Section 3, a clause that had remained obscure and varied in interpretation.
This clarity now becomes indispensable for creating a robust oversight system that does not hinge solely on outdated standards. The government is expected to convene expert panels soon to design mechanisms that will spur efficiency, safety, and long term innovation.
In the chamber, some legislators known for their stubborn stance on regulatory expansion attempted to thwart the bill, warning that the added responsibilities might push smaller manufacturers perilously close to collapse.
Yet others, speaking with rare candour, argued that public safety could no longer be left to chance or the combustible mix of weak enforcement and unchecked market forces.
The revised bill also expands rules for distribution, storage, and regulation of therapeutic goods, ensuring they are no longer strewn across loosely monitored supply chains.
Supporters described the reform as a testament to persistence and flair, especially in a sector too often rattled by counterfeit products, regulatory erosion, and administrative bottlenecks.
One member referred to the regulatory overhaul as a moment of ‘institutional redemption,’ a chance to correct past oversights that had pushed vulnerable patients toward medical oblivion.
Another, with characteristic benevolence, emphasised that the reform was not meant to punish stakeholders but to protect citizens who often fall prey to unsafe products.
